Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-06-05
2007-06-05
Whiteman, Brian (Department: 1635)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
09380203
ABSTRACT:
Disclosed are transgenic animals and transfected cell lines expressing a protein associated with Alzheimer's Disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas. Also disclosed is the use of such transgenic animals and transfected cell lines to screen potential drug candidates for treating or preventing Alzheimer's disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas. The invention also relates to new antisense oligonucleotides, ribozymes, triplex forming DNA and external guide sequences that can be used to treat or prevent Alzheimer's disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas.
REFERENCES:
patent: 4873191 (1989-10-01), Wagner et al.
patent: 5168053 (1992-12-01), Altman et al.
patent: 5830670 (1998-11-01), de la Monte et al.
patent: 5948634 (1999-09-01), de la Monte et al.
patent: 5948888 (1999-09-01), de la Monte et al.
patent: 6071705 (2000-06-01), Wands et al.
patent: 6245523 (2001-06-01), Altieri
patent: 0 263 740 (1988-04-01), None
patent: WO 89/03849 (1989-05-01), None
patent: WO 90/06993 (1990-06-01), None
patent: WO 92/07065 (1992-04-01), None
patent: WO 94/23756 (1994-10-01), None
patent: WO 96/15272 (1996-05-01), None
patent: WO 96/40895 (1996-12-01), None
Anderson, Human gene therapy, 1998, NATURE, vol. 392, pp. 25-30.
Chiu et al., Optimizing energy potential for success in protein tertiary structure prediction, 1998, Folding & Design, vol. 3, pp. 223-228.
Verma et al., Gene therapy- promises, problems and prospects, 1997, NATURE, vol. 389, pp. 239-242.
JT Ngo et al., The Protein Folding Problem andTertiary Structure Prediction, “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,”1994, vol. 14, pp. 491-494.
JM Frangiskakis et al, Cell, “LIM-kinase1 Hemizygosity Implicated in Impaired Visuospatial Constructive Cognition,” Jul. 1996, vol. 86, pp. 59-69.
de la Monte, S.M., “Regional and Maturation-associated Expression of Endothel in 2 in Rat Gastronintestional Tract,”J. Histchem. Cytochem. 43:203-209 (Feb. 1995).
de la Monte, S.M., et al., “Aberrant GAP-43 Gene Expression in Alzheimer's Disease,”Am. J. Pathol. 147:934-946 (Oct. 1995).
de la Monte, S.M., and Bloch, K.D., “Aberrant Expression of the Constitutive Endothelial Nitric Oxide Synthase Gene in Alzheimer Disease,”Mol. Chem. Neuropathol. 30:139-159 (Jan./Feb. 1997).
Gossler, A., et al., “Transgenesis by means of blastocyst-derived embryonic stem cell lines,”PNAS USA 83:9065-9069 (Dec. 1986).
Gross, J., et al., “Isolation, Characterization, and Distribution of an Unusual Pancreatic Human Secretory Protein,”J. Clin. Invest. 76:2115-2126 (Dec. 1985).
The Huntington's Disease Collaborative Research Group, “A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington's Disease Chromosomes,”Cell 72:971-983 (Mar. 1993).
Kosaka, K., “Dementia and Neuropathology in Lewy Body Disease,”Adv. Neurol. 60: 456-463 (1993).
Ozturk, M., et al., “Elevated levels of an exocrine pancreatic secretory protein in Alzheimer disease brain,”PNAS USA 86:419-423 (Jan. 1989).
Quon, D., et al., “Formation of β-amyloid protein deposits in brains of transgenic mice,”Nature 352:239-241 (Jul. 1991).
Dialog File 351, Accession No. 88-100135/198815, Derwent WPI English Language abstract for EP 0 263 740 A (printed Dec. 3, 1999).
Games, D. et al., “Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein,”Nature 373:523-527 (Feb. 1995) (Publisher: Nature Publishing Group).
Lannfelt, L. et al., “Alzheimer's disease: molecular genetics and transgenic animal models,”Behavioural Brain Research 57(2): 207-213 (1993) (Publisher: Elsevier Science).
Marx, J., “Major Setback for Alzheimer's Models, ”Science 255:1200-1201 (Mar. 1992) (Publisher: American Association for the Advancement of Science).
Pursel, V.G. et al., “Genetic Engineering of Livestock,”Science 244:1281-1288 (Jun. 1989) (Publisher: American Association for the Advancement of Science).
Salter, D.W. et al., “Transgenic Chickens: Insertion of Retroviral Genes into the Chicken Germ Line,”Virology 157:236-240 (1987) (Publisher: Academic Press).
Linder, C.C., “The Influence of Genetic Background on Spontaneous and Genetically Engineered Mouse Models of Complex Diseases,”Lab Animal 30: 34-39, Nature America (May 2001).
Rülicke, T., and Hübscher, U., “Germ line transformation of mammals by pronuclear microinjection,”Exp. Physiol. 85:589-601, The Physiological Society (Nov. 2000)..
Strojek, R.M., and Wagner, T.E., “The Use of Transgenic Animal Techniques for Livestock Improvement,”Genet. Eng. 10:221-246, Plenum Press (1988).
Houdebine, L.-M., “Production of pharmaceutical proteins from transgenic animals,”J. Biotechnol. 34:269-287, Elsevier Science B.V. (1994).
Mullins, L.J., and Mullins, J.J., “Transgenesis in the Rat and Larger Mammals,”J. Clin. Invest. 97:1557-1560, The American Society for Clinical Investigation, Inc. (Apr. 1996).
Bishop, J.O., “Chromosomal insertion of foreign DNA,”Reprod. Nutr. Dev. 36:607-618, Elsevier/INRA (Nov.-Dec. 1996).
Polejaeva, I.A., and Campbell, K.H.S., “New Advances in Somatic Cell Nuclear Transfer: Application in Transgenesis,”Theriogenology 53:117-126, Elsevier Science Inc. (Jan. 2000).
Wall, R.J. “Transgenic Livestock: Programs and Prospects for the Future,”Theriogenology 45:57-68, Elsevier Science Inc. (Jan. 1996).
Sigmund, C.D. “Viewpoint: Are Studies in Genetically Altered Mice Out of Control?”Arterioscler. Thromb. Vasc. Biol. 20:1425-1429, Lippincott Williams & Wilkins (Jun. 2000).
Yamada, K., and Nabeshima, T., “Animal models of Alzheimer's disease and evaluation of anti-dementia drugs,”Pharmacol. Ther. 88:93-113, Elsevier Science Inc. (Nov. 2000).
Bloch, D.B., et al., “Identification and Characterization of a Leukocyte-specific Component of the Nuclear Body,”J. Biol. Chem. 271:29198-29204 (Nov. 1996).
Brinster, R.L., et al., “Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs,”PNAS USA82:4438-4442 (Jul. 1985).
de le Monte, S.M. et al., “Enhanced Expression of an Exocrine Pancreatic Protein in Alzheimer's Disease and the Developing Human Brain,”J. Clin. Invest. 86:1001-1013 (Sep. 1990).
De La Monte Suzanne
Wands Jack R.
The General Hospital Corporation
Whiteman Brian
LandOfFree
Transgenic animals and cell lines for screening drugs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic animals and cell lines for screening drugs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic animals and cell lines for screening drugs... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3835433